Putative supramolecular complexes formed by carotenoids and xanthophylls with ascorbic acid to reverse multidrug

József Molnár1, Julianna Serly, Rozália Pusztai

  • 1Department of Medical Microbiology and Immunobiology, University of Szeged, Dóm tér 10., Szeged 6720, Hungary. molnarj@comser.szote.u-szeged.hu

Anticancer Research
|January 31, 2012
PubMed
Abstract

Insights

Certain carotenoids and ascorbic acid show anticancer potential by inhibiting cancer cell drug resistance. Capsorubin demonstrates significant antiproliferative effects and accumulates in cancer cell nuclei, suggesting therapeutic applications.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Background:

  • Investigating the molecular mechanisms of carotenoids and xanthophylls interacting with ascorbic acid in cancer cells.
  • Determining the potential anticancer effects of these compounds.

Purpose of the Study:

  • To elucidate the interaction between specific carotenoids/xanthophylls and ascorbic acid.
  • To evaluate their efficacy in combating cancer cells and drug resistance.

Main Methods:

  • Utilizing flow cytometry to measure drug accumulation in transfected cell lines and human lung cancer cells.
  • Assessing anticancer effects in vivo using mouse models.

Main Results:

  • Several carotenoids demonstrated inhibition of multidrug resistance in cancer cells.
  • Ascorbic acid enhanced the effects of some xanthophylls, but not capsanthin.
  • Capsorubin exhibited a significant antiproliferative effect (85%) on A549 lung cancer cells, unlike capsanthin (12%).
  • Capsorubin reduced immediate-early tumor antigen expression and selectively accumulated in cancer cell nuclei.

Conclusions:

  • A potential complex formation between membrane-bound capsorubin and ascorbic acid was proposed.
  • This interaction could be a valuable target for experimental chemotherapy strategies.

Related Concept Videos

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Radical Autoxidation01:20

Radical Autoxidation

The oxidation of an organic compound in the presence of air or oxygen is called autoxidation. For example, cumene reacts with oxygen to form hydroperoxide. Autoxidation involves initiation, propagation, and termination steps. Many organic compounds are susceptible to autoxidation—especially ethers in the presence of oxygen, which form hydroperoxides. Even though this reaction is slow, old ether bottles contain small amounts of peroxide, which leads to laboratory explosions during ether...
The Supercomplexes in the Crista Membrane01:41

The Supercomplexes in the Crista Membrane

The mitochondrial cristae membrane is the primary site for the oxidative phosphorylation (OXPHOS) process of energy conversion mediated through respiratory complexes I to V. These complexes have been widely studied for decades, and it has been proven that they form supramolecular structures called respiratory supercomplexes (SC). These higher-order complexes may be crucial in maintaining the biochemical structure and improving the physiological activity of the individual complexes while...